PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
42.52K
Worse than RIGL's estimated revenue of 171.80M.
-8.50K
Better than RIGL's estimated ebitda of -26.28M.
-1.41
Worse than RIGL's estimated eps of 0.39.
-41.31M
Worse than RIGL's estimated net income of 6.57M.
-8.50K
Better than RIGL's estimated ebit of -27.84M.
1.58M
Better than RIGL's estimated sg&a expense of 130.27M.
Analyze DCF forecasts for the company and compare them with competitors.
1.14M
Worse than RIGL's revenue of 149.24M.
No Data
No DCF data available for this metric in the selected year.
-24.44M
Worse than RIGL's ebitda of -11.29M.
-2136.36%
Worse than RIGL's ebitda margin of -7.56%.
-24.96M
Worse than RIGL's ebit of -12.45M.
-2182.17%
Worse than RIGL's ebit margin of -8.34%.
524.00K
Better than RIGL's depreciation of 1.16M.
77.83M
Worse than RIGL's total cash of 124.97M.
6803.23%
Better than RIGL's cash as percentage of revenue of 83.74%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
5.54M
Worse than RIGL's accounts payable of 3.79M.
483.83%
Worse than RIGL's payables as percentage of revenue of 2.54%.
-133.00K
Worse than RIGL's capital expenditure of -627.00K.
-11.63%
Better than RIGL's capex as percentage of revenue of -0.42%.
4.99%
Better than RIGL's weighted average cost of capital (wacc) of 10.78%.
5.02%
Better than RIGL's cost of equity of 10.36%.
4.08%
Better than RIGL's cost of debt of 13.20%.
-0.23
Better than RIGL's beta of 1.33.
30.07M
Worse than RIGL's diluted shares outstanding of 17.69M.
1.57M
Better than RIGL's total debt of 59.97M.
49.31M
Worse than RIGL's total equity of 350.82M.
50.89M
Worse than RIGL's total capital of 410.79M.
3.09%
Better than RIGL's debt weighting of 14.60%.
96.91%
Better than RIGL's equity weighting of 85.40%.
-24.77M
Worse than RIGL's ebiat of -12.88M.
-23.19M
Worse than RIGL's unlevered free cash flow of -16.74M.
2.00%
Equal to RIGL's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than RIGL's net debt of 3.22M.
71.33M
Better than RIGL's equity value of -795.30M.
2.37
Better than RIGL's equity value per share of -44.97.